Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing

Q&A with Eric Langer, about the evolution of the role of CMO’s

…
July 7, 2014 - Process Development Forum

This week Process Development Forum speaks with Eric Langer, President and Managing Partner at BioPlan Associates, and the author of a number of biopharma s

…

Concentrating Feed—an Applicable Approach to Improve Antibody P

…
June 29, 2014 - By: Ping Xu, Xiao-Ping Dai, Albert Kao, Rosario Scott, Reb Russell BioPharm International In this study, the authors evaluated different approaches to prepare highly concentrated feed media for fed-batch Chinese hamster ovary cell culture. By rais …

Global Expansion Shapes Drug Oversight
June 16, 2014 - By: Jill Wechsler BioPharm International Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.

…

Gowning Practices Provide Clues to cGMP Compliance
June 13, 2014 - By: Eric Bohn Pharmaceutical Technology

Review gowning p

…

Bureaucratic Roadblocks Threaten Biopharma Growth
June 13, 2014 - By: Jim Greenwood BioPharm International Protecting intellectual property rights is vital to biopharmaceutical innovation.

…

Challenges in Analytical Method Development and Validation
June 13, 2014 - By: Susan Haigney BioPharm International

…

Biopharma Moves to Integrated, Single-Use, Downstream Processing
June 13, 2014 - By: Cynthia Challener, PhD BioPharm International

…

Biopharma Takes a Nervous Glance Over Its Shoulder
May 19, 2014 - by: Rita Peters, BioPharm International Changes are needed to maintain US biopharma innovation leadership.

…

Novel Vaccine Technologies Meet the Need for Pandemic and Therape

…
May 18, 2014 - By: Cynthia Challener, PhD, BioPharm International New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.

…

Q&A with Industry Leader Konstantin Konstantinov, Genzyme Vice-Pr

…
May 1, 2014 - Process Development Forum This week we speak with Konstantin Konstantinov, Genzyme Vice-President Late Stage Process Development, about developments in continuous processing. 

…